Real World Evidence of Clinical Outcomes of First-Line Chemotherapy in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Patients

Volume 27, Issue 1, January 2026, Pages 371-380

Nunticha Umpawan; Panotpol Termsinsuk; Uayporn Kaosombatwattana; Charuwan Akewanlop; Krittiya Korphaisarn

• View Article
• PDF 555.69 K

Survival Outcomes in Nonmetastatic pT4 Pancreatic Ductal Adenocarcinoma: A SEER Database Analysis Comparing Neoadjuvant Therapy and Upfront Surgery with Propensity Score Matching

Volume 26, Issue 3, March 2025, Pages 847-859

Yun Zhao; Brian Kim Poh Goh; Aik Yong Chok; Ye Xin Koh

• View Article
• PDF 1.52 M

Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology

Volume 22, Issue 10, October 2021, Pages 3299-3307

Mona M Mamdouh; Hussein Okasha; Hebat Allah M Shaaban; Nesreen H Hafez; Emad Hamza El-Gemeie

• View Article
• PDF 987.98 K

Analysis of Molecular Pathways in Pancreatic Ductal Adenocarcinomas with a Bioinformatics Approach

Volume 16, Issue 6, June 2015, Pages 2561-2567

• View Article
• PDF 1.15 M

Annexin A2 and CD105 Expression in Pancreatic Ductal Adenocarcinoma is Associated with Tumor Recurrence and Prognosis

Volume 15, Issue 22, December 2014, Pages 9921-9926

• View Article
• PDF 905.67 K

Influence of Perineural Invasion on Survival and Recurrence in Patients with Resected Pancreatic Cancer

Volume 14, Issue 9, September 2013, Pages 5133-5139

• View Article
• PDF 588.54 K

Prognostic Significance of Annexin A1 Expression in Pancreatic Ductal Adenocarcinoma

Volume 13, Issue 9, September 2012, Pages 4707-4712

• View Article
• PDF 1.23 M